# FDA Inspection 1242355 - GlaxoSmithKline Biologicals - June 04, 2024

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/d49a123e-56fe-42c7-90d1-25abdeb6261d
Source feed: FDA_Inspections

> FDA Inspection 1242355 for GlaxoSmithKline Biologicals on June 04, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1242355
- Company Name: GlaxoSmithKline Biologicals
- Inspection Date: 2024-06-04
- Product Type: Biologics
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1232702 - 2024-03-12](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/70a6a284-2119-4f02-9b73-85f02c66c432)
- [FDA Inspection 1179634 - 2022-09-13](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/b7981ae6-29ac-4d33-bb97-b46c00e4538f)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8